• A case report of intrahepatic cholangiocarcinoma invading the gallbladder
• A Complex Case of Obstructive Jaundice in a Septuagenarian: Diagnostic Challenges and Therapeutic Strategies
• A Mendelian randomization analysis reveals the multifaceted role of the skin microbiota in liver cancer
• A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancer
• A special case of intrahepatic cholangiocarcinoma misdiagnosed as hepatic cystic echinococcosis
• Acute brachial artery occlusion following cisplatin-based chemotherapy: case report
• Advocate-BREAST: advocates and patients' advice to enhance breast cancer care delivery, patient experience and patient centered research by 2025
• AMDHD1 acts as a tumor suppressor and contributes to activation of TGF-beta signaling pathway in cholangiocarcinoma
• Anthelmintic activity and pathophysiological effect of anthelmintic drugs against carcinogenic liver fluke, Opisthorchis viverrini
• Appearance of sex-determining region Y-box 9 (SOX9)- and glutathione S-transferase placental form (GST-P)-positive hepatocytes as possible carcinogenic events in the early stage of furan-induced hepatocarcinogenesis
• Arterial hypoperfusion as a negative predictive marker for primary hepatic malignancies treated with Y-90 glass microsphere transarterial radioembolization
• ASO Visual Abstract: Has Management of Intrahepatic Cholangiocarcinoma Evolved with the Evidence? Trends and Practice Patterns from the National Cancer Database
• ASO Visual Abstract: Laparoscopic Radical Resection after Neoadjuvant Therapy for Intrahepatic Cholangiocarcinoma with Hepatic Hilus Involvement
• Bevacizumab Erlotinib Switch Maintenance in Chemo-Responsive Advanced Gallbladder and Cholangiocarcinoma (BEER BTC): A Multicenter, Open-Label, Randomized, Phase II Trial
• Can we talk about "futile surgery" for the upfront treatment of the perihilar cholangiocarcinoma?
• Cancer-Associated Fibroblasts in Intrahepatic Cholangiocarcinoma: Insights into Origins, Heterogeneity, Lymphangiogenesis, and Peritoneal Metastasis
• Cardiogenic shock secondary to immune checkpoint inhibitor associated myocarditis
• Cell Death and Survival Mechanisms in Cholangiocarcinogenesis
• Characteristics of SARS-CoV-2 and Opisthorchis viverrini coinfections: insights into immune responses and clinical outcomes
• Cholangiocarcinoma in early childhood
• CircUGP2 Suppresses Intrahepatic Cholangiocarcinoma Progression via p53 Signaling Through Interacting With PURB to Regulate ADGRB1 Transcription and Sponging miR-3191-5p
• Circulating tumor DNA in management of primary liver malignancy: A review of the literature and future directions
• Clinical and radiological response of Maffucci related enchondromas to mutant IDH1 inhibitor Ivosidenib
• Clinical effectiveness of DEM-TACE combined with first-line chemotherapy as the initial treatment for patients with unresectable intrahepatic cholangiocarcinoma
• Comparison of the clinicoradiological features and outcomes of lymphoepithelioma-like cholangiocarcinoma and conventional intrahepatic cholangiocarcinoma: A propensity score matching analysis
• Cross-continental insights into liver cancer: an East <em>vs.</em> West epidemiology
• Current and Emerging Applications of Artificial Intelligence (AI) in the Management of Pancreatobiliary (PB) disorders
• Delta-6 desaturase FADS2 is a tumor-promoting factor in cholangiocarcinoma
• Development and in vitro evaluation of ursolic acid-loaded poly(lactic-co-glycolic acid) nanoparticles in cholangiocarcinoma
• Development and Validation of a Stromal-Immune Signature to Predict Prognosis in Intrahepatic Cholangiocarcinoma
• Diagnostic performance of ultrasound elastography in differentiating hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a systematic review and meta-analysis
• Editorial: Clinical management of cholangiocarcinoma: surgical approaches and therapies
• Effect of photodynamic therapy on peripheral immune system for unresectable cholangiocarcinoma
• Endoscopic Retrograde Cholangiopancreatography-Related Procedures for the Differential Diagnosis of Isolated Immunoglobin G4-Related Sclerosing Cholangitis and Perihilar Cholangiocarcinoma
• Enhancement of gemcitabine sensitivity in intrahepatic cholangiocarcinoma through Saikosaponin-a mediated modulation of the p-AKT/BCL-6/ABCA1 axis
• Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
• Evaluation of combined hepatocellular-cholangiocarcinoma using CEUS LI-RADS: correlation with pathological characteristics
• Evolving approaches in advanced gallbladder cancer with complete pathological response using chemo‑immunotherapy: A case report
• Expression and function of the major histocompatibility complex (MHC) class I chain-related A (MICA)*010 in NK cell killing activity
• Feasibility Assessment of Robotic Major Hepatectomy and Bile Duct Resection in Klatskin Type IIIB Tumor with Concomitant Gallbladder Cancer
• Focal liver lesion diagnosis with deep learning and multistage CT imaging
• Future of U.S. living donor liver transplant: Donor and recipient criteria, transplant indications, transplant oncology, liver paired exchange and non-directed donor graft allocation
• Good long-term outcomes of primary sclerosing cholangitis in childhood
• Guidelines Development Group for the British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma
• Hedgehog components are overexpressed in a series of liver cancer cases
• Hepatic arterial infusion chemotherapy plus targeted therapy and immunotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a retrospective cohort study
• Hepatic arterial infusion of GEMOX plus systemic gemcitabine chemotherapy combined with lenvatinib and PD-1 inhibitor in large unresectable intrahepatic cholangiocarcinoma
• Hepatic Resection as the Primary Treatment Method for Hepatocellular Carcinoma After Orthotopic Liver Transplantation
• Hybridizing mechanistic modeling and deep learning for personalized survival prediction after immune checkpoint inhibitor immunotherapy
• Hypoxia Stimulates PYGB Enzymatic Activity to Promote Glycogen Metabolism and Cholangiocarcinoma Progression
• Identification and validation of inflammatory subtypes in intrahepatic cholangiocellular carcinoma
• Identification of whole-genome mutations and structural variations of bile cell-free DNA in cholangiocarcinoma
• IgG4 porta-hepatis pseudotumor mimicking a hilar cholangiocarcinoma
• Immunosuppression and phenotypic plasticity in an atlas of human hepatocholangiocarcinoma
• Incidence and Long-Term Outcomes of Biliary Tract Cancers in Olmsted County, Minnesota from 1976 to 2018
• Is the Prognostic Nutritional Index a Novel Prognostic Factor in Patients With Unresectable/Metastatic Gallbladder and Cholangiocarcinoma Receiving Chemotherapy?
• Knockdown of long noncoding RNA AL161431.1 inhibits malignant progression of cholangiocarcinoma
• LAMB3: Central role and clinical significance in neoplastic and non-neoplastic diseases
• Laparoscopic Radical Resection After Neoadjuvant Therapy for Intrahepatic Cholangiocarcinoma with Hepatic Hilus Involvement
• Laparoscopic Right Hemi-hepatectomy of the Bile Duct-Obstructed Area Guided by Real-Time Fluorescence Imaging
• Ligustilide Inhibits the PI3K/AKT Signalling Pathway and Suppresses Cholangiocarcinoma Cell Proliferation, Migration, and Invasion
• Liver Oligometastasis in Biliary Tract Cancer and Impact on Survival Outcomes
• Long Non-Coding RNA <em>AGAP2-AS1</em>: A Comprehensive Overview on Its Biological Functions and Clinical Significances in Human Cancers
• Long-Term Risks of Benign and Malign Complications after Endoscopic Sphincterotomy in the Management of Benign Biliopancreatic Pathology: A Cohort Study
• Lymphotoxin beta-activated LTBR/NIK/RELB axis drives proliferation in cholangiocarcinoma
• Management of Localized Intrahepatic Cholangiocarcinoma: What Exactly is the 'Evidence'?
• Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean
• microRNA profiling of exosomes derived from plasma and their potential as biomarkers for Opisthorchis viverrini-associated cholangiocarcinoma
• MSH6 germline mutations leading to Lynch syndrome-associated cholangiocarcinoma: a case report
• Multiplexed immunohistochemical analysis of the immune microenvironment of biliary tract cancers pre- &amp; post-neoadjuvant chemotherapy: case series
• New systemic treatment options for advanced cholangiocarcinoma
• Outcomes of Liver Transplantation with Incidental Intrahepatic Cholangiocarcinoma-Own Experience and a Systematic Review
• Overcoming treatment resistance in cholangiocarcinoma: current strategies, challenges, and prospects
• Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy
• Pattern and extent of intrahepatic infiltration of perihilar cholangiocarcinoma - A case-control study based on liver panoramic digital pathology
• Preoperative platelet count as an independent predictor of long-term outcomes among patients undergoing resection for intrahepatic cholangiocarcinoma
• Prognostic factors in patients with intrahepatic cholangiocarcinoma
• Prognostic impact of abdominal aortic calcification in patients who underwent hepatectomy for intrahepatic cholangiocarcinoma
• Prognostic impact of liver resection side in peri-hilar cholangiocarcinoma: A systematic review and meta-analysis
• Rapid deterioration of steatotic liver disease due to portal vein stenosis after pancreaticoduodenectomy
• Real-world use of pemigatinib for the treatment of cholangiocarcinoma in the US
• Realizing Textbook Outcomes Following Liver Resection for Hepatic Neoplasms with Development and Validation of a Predictive Nomogram
• Repeat laparoscopic liver resection after an initial open hepatectomy
• Research progress and prospect of postoperative adjuvant therapy for resectable intrahepatic cholangiocarcinoma
• Response to the letter by Buldukoglu et al. regarding our manuscript "Body mass index and survival among patients with advanced biliary tract cancer: a single-institutional study with nationwide data-based validation"
• Response to the letter: predictive score for identifying intrahepatic cholangiocarcinoma patients without lymph node metastasis: a basis for omitting lymph node dissection
• Selinexor targeting XPO1 promotes PEG3 nuclear accumulation and suppresses cholangiocarcinoma progression
• Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients
• Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8⁺ T cell exhaustion and anti-PD-1 resistance
• Strategies for treating the cold tumors of cholangiocarcinoma: core concepts and future directions
• Synchronous primary multiple cancer: distal cholangiocarcinoma of the intrapancreatic common bile duct and intraductal papillary mucinous tumor associated with ductal adenocarcinoma of the pancreatic tail
• Systematic profiling of mitochondria-related transcriptome in tumorigenesis, prognosis, and tumor immune microenvironment of intrahepatic cholangiocarcinoma: a multi-center cohort study
• Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives
• The Association of Transferrin Receptor with Prognosis and Biologic Role in Intrahepatic Cholangiocarcinoma
• The Search for Risk, Diagnostic and Prognostic Biomarkers of Cholangiocarcinoma and their Biological and Clinicopathological Significance
• The utility of next-generation sequencing in challenging liver FNA biopsies
• Transcriptomic profiling of intermediate cell carcinoma of the liver
• Treatments and prognostic outcomes of combined hepatocellular-cholangiocarcinoma with distant metastasis: an analysis based on SEER data
• UCK2 promotes intrahepatic cholangiocarcinoma progression and desensitizes cisplatin treatment by PI3K/AKT/mTOR/autophagic axis
• Unveiling the Transmission Potential of Opisthorchis viverrini and Intestinal Helminths Along the Thailand-Laos Border in Thailand